CVR Medical Corp. Share Price Deutsche Boerse AG
Equities
B3BN
CA1266321084
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.007 EUR | -26.32% | -.--% | -.--% |
Sales 2020 | - | Sales 2021 | - | Capitalization | 3.6M 3.37M 300M |
---|---|---|---|---|---|
Net income 2020 | - 0 0 | Net income 2021 | -1M -934K -83.34M | EV / Sales 2020 | - |
Net Debt 2020 | 360K 336K 30.02M | Net Debt 2021 | 434K 405K 36.16M | EV / Sales 2021 | - |
P/E ratio 2020 |
-11.5
x | P/E ratio 2021 |
-1.55
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 87.21% |
1 day | -26.32% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Rhodes
CEO | Chief Executive Officer | - | 20/21/20 |
Paul S. Blunden
PSD | President | - | 20/16/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul S. Blunden
PSD | President | - | 20/16/20 |
Phillip Bendick
BRD | Director/Board Member | - | 13/20/13 |
Joseph Lynch
BRD | Director/Board Member | - | 17/20/17 |
1st Jan change | Capi. | |
---|---|---|
-42.89% | 7.8B | |
+6.77% | 3.53B | |
-1.35% | 2.24B | |
-27.06% | 1.84B | |
-21.23% | 1.66B | |
+9.31% | 951M | |
+29.42% | 811M | |
-12.66% | 670M | |
+1.19% | 296M |
- Stock Market
- Equities
- CVM.H Stock
- B3BN Stock